Carole Ho, M.D.

Carole Ho is executive vice president of Eli Lilly and Company and president of Lilly Neuroscience.

Carole has been recognized for strategic leadership in advancing neuroscience innovation and organizational growth. With a proven ability to build and scale integrated development organizations, Carole has guided teams through the full spectrum of drug development, driving progress from early research to pivotal clinical milestones and global launches.

Before joining Lilly, Carole was the founding chief medical officer and head of development at Denali Therapeutics, where she established a dynamic development infrastructure that accelerated progress across multiple neurological indications.

Throughout her career, Carole has championed innovative approaches to clinical research, spearheaded landmark prevention trials, and cultivated partnerships that have shaped the future of neuroscience. With a foundation in neurology and biochemical sciences, she brings deep expertise and a passion for advancing patient care through bold, strategic leadership.